Skip to contentR
Rockwell Medical, Inc.
R
RMTIRockwell Medical, Inc. Q4 2022 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$19.31M$19.31Mderived+26.0% vs Q4 2021 Net Income-$2.36M-$2.36MderivedN/M vs Q4 2021 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rockwell Medical, Inc. · CIK 1041024 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$2,341,000N/M Operating Incomederived-$1,964,000N/M Operating Cash Flowderived-$112,000N/M Margins · derivedGross margin12.1%+26.7 pt vs Q4 2021
Operating margin-10.2%+44.3 pt vs Q4 2021
Net margin-12.2%+46.1 pt vs Q4 2021
ended Dec 31, 2022 · filed Mar 30, 2023 · 89 d after period end